Biotage

Biotage Debt

Delisted

The Debt of Biotage (BIOT.ST) as of Nov 3, 2026 is 250.00 M SEK. In the previous year, Debt was 259.00 M SEK — a change of -3.47% (lower).

Debt

250.00 MSEK

YoY

-3.47%

Last updated:

In 2024, Biotage's total debt was 250.00 M SEK, a -3.47% change from the 259.00 M SEK total debt recorded in the previous year.

The Biotage Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2017
0.00 SEK
Jan 1, 2018
109.40 M SEK
Jan 1, 2019
168.88 M SEK
Jan 1, 2020
161.89 M SEK
Jan 1, 2021
203.00 M SEK
Jan 1, 2022
217.00 M SEK
Jan 1, 2023
259.00 M SEK
Jan 1, 2024
250.00 M SEK
The Biotage Debt history
YEARDebtYoY
250.00 MSEK-3.47%
259.00 MSEK+19.35%
217.00 MSEK+6.90%
203.00 MSEK+25.39%
161.89 MSEK-4.14%
168.88 MSEK+54.37%
109.40 MSEK—
0.00SEK—
0.00SEK—
0.00SEK-100.00%
5.04 MSEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Biotage Stock analysis

What does Biotage do? Biotage AB is a Swedish company founded in 1983. Since then, the company has become an international leader in the development, manufacturing, and marketing of equipment, chemicals, and accessories for organic and medicinal chemistry, pharmacy, biochemistry, and food analysis. The company's business model is based on the development and marketing of innovative instruments and technologies for analytics and chromatography. Consumables and accessory products are also an important part of the business model. Biotage offers customized solutions tailored to each customer's specific needs. Biotage systems are widely used in the pharmaceutical, biotech, and academic sectors. The company is divided into four main divisions: chromatography, spectroscopy, analytics, and synthesis. In the chromatography division, Biotage offers a wide range of systems for sample preparation and analysis, including flash chromatography systems, HPLC systems, and automation solutions for column development. In the spectroscopy division, Biotage offers systems for molecular structure determination, including NMR spectrometers and FT-IR spectrometers. In the analytics division, the company specializes in mass spectrometry and offers a wide range of instruments and accessories, including HPLC-MS systems, MALDI-TOF systems, and LC-MS applications. In the synthesis division, the focus is on the development and marketing of tools for the synthesis, purification, and analysis of peptides and synthesis kits. Biotage is also known for its wide range of chemicals and accessory products. The company offers a variety of solvents, catalysts, reagents, and separation columns that can be used in organic, pharmaceutical, and biological synthesis. Accessory products include items such as activated carbon filter cartridges or membranes for various chromatography systems. Despite the wide range of products, Biotage has focused on specialized markets, particularly drug research and development, peptide synthesis, and the production of specialty chemicals. In these markets, the devices and chemicals are used to develop and produce medications and important blockbuster compounds. In conclusion, Biotage is a company that focuses on the development and marketing of instruments and technologies for analytics and chromatography. Thanks to its strong market presence and innovative products, the company has become an internationally recognized manufacturer. Biotage is headquartered in Sweden, but its global network of sales and service centers enables global presence and development. Biotage is one of the most popular companies on Eulerpool.

Debt Details

Understanding Biotage's Debt Structure

Biotage's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Biotage's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Biotage’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Biotage’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Biotage stock

Debt of Biotage is 250.00 M SEK in 2024.

Debt of Biotage changed from 259.00 M SEK to 250.00 M SEK, representing a -3.47% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Debt Biotage since 2006 – with annual values, charts, and detailed analysis.

Debt's SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's Biotage historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Biotage

All Key Metrics — Biotage